Researchers will examine new treatments to improve outcomes for people with advanced kidney disease and those who have experienced an ischaemic stroke.
A major clinical trial has found that allopurinol does not prevent worsening of kidney disease – despite up to 20 per cent of kidney disease patients being prescribed the medication.
